Eileen Rakovitch

10PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBehavioural epidemiologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 28, 2024
Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ.

Ezra Hahn, Rinku Sutradhar, Lawrence Paszat

|Feb 23, 2024
Personalizing the Treatment of Women with Ductal Carcinoma In Situ (DCIS) Using the DCIS Score: A Qualitative Study on Score Use.

Mary Ann O'Brien, Lawrence Paszat, Tutsirai Makuwaza

|Jun 27, 2023
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?

Ezra Hahn, Danielle Rodin, Rinku Sutradhar

|Jun 16, 2023
Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery.

Danielle Rodin, Rinku Sutradhar, Katarzyna J Jerzak

|Apr 08, 2021
DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS.

Eileen Rakovitch, Sameer Parpia, Anne Koch

|Dec 28, 2020
21-Gene Assay and Breast Cancer Mortality in Ductal Carcinoma In Situ.

Eileen Rakovitch, Rinku Sutradhar, Sharon Nofech-Mozes

Pageof 2